Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Safety Study of Aminolevulinic Acid (ALA) to Improve Visibility of Brain Tumors During Surgery

The recruitment status of this study is unknown because the information has not been verified recently.
Verified February 2010 by West Penn Allegheny Health System.
Recruitment status was  Recruiting
Sponsor:
Collaborator:
DUSA Pharmaceuticals, Inc.
Information provided by:
West Penn Allegheny Health System
ClinicalTrials.gov Identifier:
NCT00961090
First received: August 17, 2009
Last updated: June 27, 2011
Last verified: February 2010
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: October 2013
  Estimated Primary Completion Date: August 2013 (Final data collection date for primary outcome measure)